Filing Details

Accession Number:
0001325812-15-000019
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-03 18:48:21
Reporting Period:
2015-02-27
Filing Date:
2015-03-03
Accepted Time:
2015-03-03 18:48:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
873303 Sarepta Therapeutics Inc. SRPT Pharmaceutical Preparations (2834) 930797222
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522780 Md M. Edward Kaye 215 First Street, Suite 7
Cambridge MA 02142
Svp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-27 800 $11.82 1,311 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Acquisiton 2015-02-27 9,200 $0.00 9,200 $13.90
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2015-02-27 153,800 $0.00 153,800 $13.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,200 2025-02-27 No 4 A Direct
153,800 2025-02-27 No 4 A Direct
Footnotes
  1. Includes shares acquired under the Sarepta Therapeutics, Inc. 2013 Employee Stock Purchase Plan; 511 shares were acquired on August 29, 2014 at a price of $19.4905 and 800 shares were acquired on February 27, 2015.
  2. 25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.